BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:XmAb657 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of XmAb657\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07284797-6548@assetmemo.bio
DTSTAMP:20261121T005829Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:XmAb657: Phase 1 readout est. (NCT07284797)
DESCRIPTION:XmAb657\, phase 1\, Idiopathic Inflammatory Myopathies.\nStudy:
  A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and
  Participants With Autoimmune Diseases\nEstimated primary completion: Octo
 ber 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/xmab657#upc
 oming-events\nRegistry record: https://clinicaltrials.gov/study/NCT0728479
 7
URL:https://assetmemo.bio/drug/xmab657#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
